P2X purinergic receptor
P2X purinergic receptor is a famliy of ATP-gated cation channels. It is widely distributed in the body and paly an important role in regulation of synaptic transmission, vascular endothelium and nociception etc.
Products for P2X purinergic receptor
- Cat.No. Product Name Information
- BCC1251 IvermectinPositive allosteric modulator for P2X4 receptor
- BCC1316 A 438079P2X7 receptor antagonist,competitive and selective
- BCC1317 A 438079 hydrochlorideCompetitive P2X7 antagonist
- BCC1320 A-317491P2X3 and P2X2/3 receptor antagonist
- BCC1681 KN-92 hydrochlorideInactive derivative of KN-93,control compound
- BCC1682 KN-92 phosphateK+ channel (Kv) blocker. Inactive analog of KN 93
- BCC1683 KN-93CaM kinase II inhibitor; also K+ channel blocker (KV)
- BCC3602 KN-62Non-competitive P2X7 antagonist
- BCC6005 AZ 10606120 dihydrochloridePotent P2X7 receptor antagonist
- BCC6155 TC-P 262Selective P2X3, P2X2/3 antagonist
- BCC6157 Ro 51Potent P2X3, P2X2/3 antagonist
- BCC6198 A 804598Potent and selective P2X7 antagonist
- BCC6333 Purotoxin 1Potent P2X3 modulator
- BCC6725 PPADS tetrasodium saltP2 purinergic antagonist
- BCC6749 iso-PPADS tetrasodium saltP2X antagonist
- BCC6918 2-Methylthioadenosine triphosphate tetrasodium saltP2 purinergic agonist
- BCC6964 NF 279Potent and selective P2X1 antagonist
- BCC6966 MRS 2219Potentiates P2X1-mediated responses
- BCC6985 NF 023Selective, competitive P2X1 antagonist
- BCC7015 PPNDSPotent, selective P2X1 antagonist
- BCC7043 NF 449Highly selective P2X1 antagonist
- BCC7079 Suramin hexasodium saltNon-selective P2 antagonist
- BCC7276 Ro 0437626Selective P2X1 antagonist
- BCC7367 NF 157Selective P2Y11/P2X1 antagonist
- BCC7373 TNP-ATP triethylammonium saltPotent, selective P2X antagonist
- BCC7404 NF 110Potent P2X3 antagonist
- BCC7548 RO-3Selective P2X3 and P2X2/3 antagonist
- BCC7643 BzATP triethylammonium saltP2X7 agonist. Also P2X1 and P2Y1 partial agonist
- BCC7646 AZ 11645373Potent and selective human P2X7 antagonist
- BCC7717 5-BDBDPotent P2X4 receptor antagonist
- BCC7855 ATPγS tetralithium salt